Abstract
Expression of the transcription factor hypoxia-inducible factor 1 (HIF-1), which plays a key role in cellular adaptation to hypoxia, was investigated in normal colorectal mucosa (ten), adenomas (61), and carcinomas (23). Tissue samples were analyzed for HIF-1 alpha, its upstream regulators, von Hippel-Lindau factor, AKT, and mammalian target of rapamycin (mTOR) and its downstream targets glucose transporter 1 (GLUT1), carbonic anhydrase IX, stromal-cell-derived factor 1 (SDF-1) by immunohistochemistry. In normal colorectal mucosa, HIF-1 alpha was observed in almost all nuclei of surface epithelial cells, probably secondary to a gradient of oxygenation, as indicated by pimonidazole staining. The same staining pattern was present in 87% of adenomas. In carcinomas, HIF-1 alpha was present predominantly around areas of necrosis (78%). Active AKT and mTOR, were present in all adenomas, carcinomas, and in normal colorectal mucosa. GLUT1 and SDF-1 were present in the normal surface epithelium of all adenoma cases, whereas in the carcinoma GLUT1 was located around necrotic regions and SDF-1 was present in all epithelial cells. In conclusion, HIF-1 alpha appears to be physiologically expressed in the upper part of the colorectal mucosa. The present observations support that upregulation of HIF-1 alpha and its downstream targets GLUT1 and SDF-1 in colorectal adenomas and carcinomas may be due to hypoxia, in close interaction with an active phosphatidylinositol 3-kinases-AKT-mTOR pathway.
| Original language | English |
|---|---|
| Pages (from-to) | 535-544 |
| Number of pages | 10 |
| Journal | Virchows Archives |
| Volume | 452 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 2008 |
Keywords
- Adenoma
- Adult
- Aged
- Aged, 80 and over
- Antigens, Neoplasm
- Carbonic Anhydrases
- Chemokine CXCL12
- Colorectal Neoplasms
- Female
- Gene Expression Regulation
- Gene Expression Regulation, Neoplastic
- Glucose Transporter Type 1
- Humans
- Hypoxia-Inducible Factor 1, alpha Subunit
- Intestinal Mucosa
- Male
- Middle Aged
- Oncogene Protein v-akt
- Protein Kinases
- TOR Serine-Threonine Kinases